Africa Pharmaceutical Regulatory Affairs Market Size, Share & Trends Report

Africa Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By Category, By Indication, By Product Stage, By Service Provider, By Company Size, By Country, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68040-121-3
  • Number of Report Pages: 150
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2021
  • Forecast Period: 2023 - 2030 
  • Industry: Healthcare

Market Segmentation

  • Africa Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
    • Regulatory Consulting
    • Legal Representation
    • Regulatory Writing & Publishing
      • Writing
      • Publishing
    • Product Registration & Clinical Trial Applications
    • Other Services
  • Africa Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
    • Drugs
    • Biologics
  • Africa Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
    • Oncology
    • Neurology
    • Cardiology
    • Immunology
    • Others
  • Africa Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
    • Preclinical
    • Clinical studies
    • PMA
  • Africa Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
    • In-house
    • Outsourcing
  • Africa Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
    • Small
    • Medium
    • Large
  • Africa Pharmaceutical Regulatory Affairs Country Outlook (Revenue, USD Million, 2018 - 2030)
    • Africa 
      • Africa Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
        • Regulatory Consulting
        • Legal Representation
        • Regulatory Writing & Publishing
          • Writing
          • Publishing
        • Product Registration & Clinical Trial Applications
        • Other Services
      • Africa Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
        • Drugs
        • Biologics
      • Africa Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
        • Neurology
        • Cardiology
        • Immunology
        • Others
      • Africa Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
        • Preclinical
        • Clinical studies
        • PMA
      • Africa Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
        • In-house
        • Outsourcing
      • Africa Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
        • Small
        • Medium
        • Large
      • South Africa
        • South Africa Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • South Africa Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • South Africa Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • South Africa Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • South Africa Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • South Africa Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Botswana
        • Botswana Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Botswana Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Botswana Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Botswana Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Botswana Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Botswana Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Namibia
        • Namibia Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Namibia Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Namibia Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Namibia Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Namibia Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Namibia Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Zimbabwe
        • Zimbabwe Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Zimbabwe  Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Zimbabwe Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Zimbabwe Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Zimbabwe Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Zimbabwe Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Algeria
        • Algeria Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Algeria Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Algeria Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Algeria Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Algeria Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Algeria Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Zambia
        • Zambia Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Zambia Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Zambia Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Zambia  Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Zambia Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Zambia Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Tanzania
        • Tanzania Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Tanzania Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Tanzania Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Tanzania Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Tanzania Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Tanzania Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Rwanda
        • Rwanda Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Rwanda Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Rwanda Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Rwanda Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Rwanda Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Rwanda Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Ghana
        • Ghana Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Ghana Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Ghana Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Ghana Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Ghana Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Ghana Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Nigeria
        • Nigeria Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Nigeria Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Nigeria Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Nigeria Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Nigeria Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Nigeria Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Uganda
        • Uganda Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Uganda Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Uganda Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Uganda Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Uganda Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Uganda Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Mauritius
        • Mauritius Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Mauritius Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Mauritius Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Mauritius  Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Mauritius Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Mauritius Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Kenya
        • Kenya Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Kenya Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Kenya Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Kenya Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Kenya Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Kenya Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large
      • Rest of Africa 
        • Rest of Africa Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)
          • Regulatory Consulting
          • Legal Representation
          • Regulatory Writing & Publishing
            • Writing
            • Publishing
          • Product Registration & Clinical Trial Applications
          • Other Services
        • Rest of Africa Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)
          • Drugs
          • Biologics
        • Rest of Africa Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Immunology
          • Others
        • Rest of Africa  Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)
          • Preclinical
          • Clinical studies
          • PMA
        • Rest of Africa Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
          • In-house
          • Outsourcing
        • Rest of Africa Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)
          • Small
          • Medium
          • Large

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon